China Dominating Global Tetraspecific Antibody Clinical Trials Development Landscape

[admin]

Chinese Companies To Play Dominant role In Development Of Global Tetraspecific Antibodies Market Finds Kuick Research ReportDelhi, March 21, 2023 (GLOBE NEWSWIRE) -- China has emerged as a dominant force in the field of tetraspecific antibodies, leading the way in clinical trials and showing promising results in the treatment of cancer. With the growing number of Chinese biotech and biopharma companies investing in the development of this novel therapy, the future of tetraspecific antibodies loo